Takasu Naoki, Nomura Takashi, Fukumoto Tsuyoshi, Shibata Kenichi, Kamio Yukinori, Hachiya Osamu, Kimura Wataru
Dept. of Gastroenterological and General Surgery, Yamagata University Faculty of Medicine, Japan.
Gan To Kagaku Ryoho. 2009 Jan;36(1):111-3.
We report a case of advanced gastric cancer that showed a complete histological response to neoadjuvant chemotherapy. The patient, a 56-year-old man, was diagnosed as having advanced gastric cancer with lymph node metastases( cT3 cN1 cH0 cP0 cM0, cStageIIIA). He was initially treated with combined neoadjuvant chemotherapy comprising CPT-11+S-1. S-1(120 mg/day)was administered orally for 21 days, followed by CPT-11(130 mg/body)divon days 1 and 15. The primary lesion and lymph node metastases were diminished by 2 courses of chemotherapy, and no serious toxicities were observed. Distal gastrectomy and lymph node dissection(D2)were performed. Only a small ulcer was observed on the resected stomach. Histological examination of the resected stomach and lymph nodes revealed no remaining viable cancer cells. The patient has been doing well without any recurrence for 1 year since the start of treatment.
我们报告了一例晚期胃癌患者,该患者对新辅助化疗显示出完全的组织学缓解。患者为一名56岁男性,被诊断为伴有淋巴结转移的晚期胃癌(cT3 cN1 cH0 cP0 cM0,cⅢA期)。他最初接受了由CPT-11+S-1组成的新辅助化疗联合方案。S-1(120毫克/天)口服21天,随后在第1天和第15天静脉注射CPT-11(130毫克/体)。经过2个疗程的化疗,原发灶和淋巴结转移灶缩小,未观察到严重毒性反应。进行了远端胃切除术和淋巴结清扫术(D2)。在切除的胃上仅观察到一个小溃疡。对切除的胃和淋巴结进行组织学检查,未发现残留的存活癌细胞。自治疗开始以来,该患者已良好生存1年,无任何复发。